Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Orefice

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 6, 2004
Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosisA Perretti, P Balbi, G Orefice, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 25, 2012
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practiceR Lanzillo, S Bonavita, M Quarantelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosisA Prinster, M Quarantelli, R Lanzillo, et al.
Acta Neurologica Scandinavica|November 24, 2011
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective studyR Lanzillo, M Quarantelli, S Bonavita, et al.
Italian Journal of Neurological Sciences|February 1, 1989
The idiopathic hypereosinophilic syndrome. Clinical, electrophysiological and histological study of a caseM Marolda, G Orefice, F Barbieri, et al.
Acta Neurologica Scandinavica|August 9, 2016
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex<sup>®</sup>A Carotenuto, R Iodice, M Petracca, et al.
Eye (London, England)|December 19, 2015
Anatomical and functional retinal changes in multiple sclerosisG Cennamo, M R Romano, E C Vecchio, et al.
European Journal of Neurology|August 26, 2006
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosisG Coppola, R Lanzillo, C Florio, et al.
European Journal of Neurology|May 19, 2011
Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patientsR Lanzillo, C Di Somma, M Quarantelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 11, 2011
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapyR Lanzillo, G Orefice, A Prinster, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 6, 2004
Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosisA Perretti, P Balbi, G Orefice, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 25, 2012
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practiceR Lanzillo, S Bonavita, M Quarantelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosisA Prinster, M Quarantelli, R Lanzillo, et al.
Acta Neurologica Scandinavica|November 24, 2011
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective studyR Lanzillo, M Quarantelli, S Bonavita, et al.
Italian Journal of Neurological Sciences|February 1, 1989
The idiopathic hypereosinophilic syndrome. Clinical, electrophysiological and histological study of a caseM Marolda, G Orefice, F Barbieri, et al.
Acta Neurologica Scandinavica|August 9, 2016
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex<sup>®</sup>A Carotenuto, R Iodice, M Petracca, et al.
Eye (London, England)|December 19, 2015
Anatomical and functional retinal changes in multiple sclerosisG Cennamo, M R Romano, E C Vecchio, et al.
European Journal of Neurology|August 26, 2006
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosisG Coppola, R Lanzillo, C Florio, et al.
European Journal of Neurology|May 19, 2011
Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patientsR Lanzillo, C Di Somma, M Quarantelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 11, 2011
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapyR Lanzillo, G Orefice, A Prinster, et al.
Pageof 9